These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
621 related items for PubMed ID: 15932367
1. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Aliment Pharmacol Ther; 2005 Jun 01; 21(11):1365-75. PubMed ID: 15932367 [Abstract] [Full Text] [Related]
2. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Hillilä MT, Färkkilä MA. Aliment Pharmacol Ther; 2004 Aug 01; 20(3):339-45. PubMed ID: 15274671 [Abstract] [Full Text] [Related]
3. Prevalence of irritable bowel syndrome: a community survey. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Br J Gen Pract; 2004 Jul 01; 54(504):495-502. PubMed ID: 15239910 [Abstract] [Full Text] [Related]
4. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Katsinelos P, Lazaraki G, Kountouras J, Paroutoglou G, Oikonomidou I, Mimidis K, Koutras C, Gelas G, Tziomalos K, Zavos C, Pilpilidis I, Chatzimavroudis G. Eur J Gastroenterol Hepatol; 2009 Feb 01; 21(2):183-9. PubMed ID: 19212207 [Abstract] [Full Text] [Related]
5. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Sperber AD, Shvartzman P, Friger M, Fich A. Eur J Gastroenterol Hepatol; 2007 Jun 01; 19(6):441-7. PubMed ID: 17489053 [Abstract] [Full Text] [Related]
6. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, Hamm LR, Cook SF, Tennis P, Mangel AW. Aliment Pharmacol Ther; 2005 Nov 15; 22(10):935-42. PubMed ID: 16268967 [Abstract] [Full Text] [Related]
7. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Ringel Y, Williams RE, Kalilani L, Cook SF. Clin Gastroenterol Hepatol; 2009 Jan 15; 7(1):68-72; quiz 3. PubMed ID: 19124113 [Abstract] [Full Text] [Related]
8. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. Aliment Pharmacol Ther; 2004 Jun 01; 19(11):1217-24. PubMed ID: 15153175 [Abstract] [Full Text] [Related]
9. Comorbidity and use of health-care services among irritable bowel syndrome sufferers. Hillilä MT, Siivola MT, Färkkilä MA. Scand J Gastroenterol; 2007 Jul 01; 42(7):799-806. PubMed ID: 17558902 [Abstract] [Full Text] [Related]
10. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. Han SH, Lee OY, Bae SC, Lee SH, Chang YK, Yang SY, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH, Kim TH. J Gastroenterol Hepatol; 2006 Nov 01; 21(11):1687-92. PubMed ID: 16984590 [Abstract] [Full Text] [Related]
11. Stability of irritable bowel syndrome using a Rome II-based classification. Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Cook SF. Aliment Pharmacol Ther; 2006 Jan 01; 23(1):197-205. PubMed ID: 16393298 [Abstract] [Full Text] [Related]
12. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients. Usai P, Manca R, Cuomo R, Lai MA, Boi MF. Dig Liver Dis; 2007 Sep 01; 39(9):824-8. PubMed ID: 17644056 [Abstract] [Full Text] [Related]
13. Internet-based assessment of bowel symptoms and quality of life. Enck P, Kowalski A, Martens U, Klosterhalfen S. Eur J Gastroenterol Hepatol; 2006 Dec 01; 18(12):1263-9. PubMed ID: 17099374 [Abstract] [Full Text] [Related]
14. Irritable bowel syndrome and the Rome III criteria: for better or for worse? Gwee KA. Eur J Gastroenterol Hepatol; 2007 Jun 01; 19(6):437-9. PubMed ID: 17489052 [Abstract] [Full Text] [Related]
15. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Mearin F, Badía X, Balboa A, Benavent J, Caballero AM, Domínguez-Muñoz E, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M, RITMO Group. Aliment Pharmacol Ther; 2006 Mar 15; 23(6):815-26. PubMed ID: 16556184 [Abstract] [Full Text] [Related]
16. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Jung HK, Halder S, McNally M, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Aliment Pharmacol Ther; 2007 Aug 01; 26(3):453-61. PubMed ID: 17635380 [Abstract] [Full Text] [Related]
17. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Hungin AP, Whorwell PJ, Tack J, Mearin F. Aliment Pharmacol Ther; 2003 Mar 01; 17(5):643-50. PubMed ID: 12641512 [Abstract] [Full Text] [Related]
18. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Vandvik PO, Lydersen S, Farup PG. Scand J Gastroenterol; 2006 Jun 01; 41(6):650-6. PubMed ID: 16716962 [Abstract] [Full Text] [Related]
19. The usual medical care for irritable bowel syndrome. Whitehead WE, Levy RL, Von Korff M, Feld AD, Palsson OS, Turner M, Drossman DA. Aliment Pharmacol Ther; 2004 Dec 01; 20(11-12):1305-15. PubMed ID: 15606392 [Abstract] [Full Text] [Related]
20. Prevalence of irritable bowel syndrome among undergraduates in Southeast China. Dai N, Cong Y, Yuan H. Dig Liver Dis; 2008 Jun 01; 40(6):418-24. PubMed ID: 18339591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]